RedHill Biopharma regains Nasdaq stockholders’ equity compliance
RedHill Biopharma (RDHL) has regained compliance with Nasdaq as confirmed by Nasdaq on November 26, 2025. More on RedHill Seeking Alpha’s Quant Rating on RedHill Financial information for RedHill
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments